Cargando…
Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia
BACKGROUND: Medication risk communication is essential to ensure the safe use of medicines. However, very few nations worldwide have established effective risk communication systems. To date, the effectiveness of risk communication among healthcare professionals in Malaysia has never been evaluated....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253255/ https://www.ncbi.nlm.nih.gov/pubmed/35788213 http://dx.doi.org/10.1186/s12889-022-13703-x |
_version_ | 1784740440404131840 |
---|---|
author | Panickar, Rema Aziz, Zoriah Kamarulzaman, Adeeba |
author_facet | Panickar, Rema Aziz, Zoriah Kamarulzaman, Adeeba |
author_sort | Panickar, Rema |
collection | PubMed |
description | BACKGROUND: Medication risk communication is essential to ensure the safe use of medicines. However, very few nations worldwide have established effective risk communication systems. To date, the effectiveness of risk communication among healthcare professionals in Malaysia has never been evaluated. Our study aimed to (i) evaluate doctors’ and pharmacists’ awareness of regulatory risk communication methods; (ii) identify factors predicting the usefulness of these methods; and (iii) compare respondents’ preferences for risk communication to outline suggestions for enhancement. METHODS: We conducted a nationwide cross-sectional survey covering four commonly used risk communications, namely a national drug bulletin, safety alerts, Direct Healthcare Professional Communication letters (DHPCs), and educational materials. Multiple logistic regression analysis was used to determine the association between independent variables and the usefulness of risk communication. We performed qualitative analysis of free-text responses to gain insights on respondents’ perspectives on risk communication. RESULTS: Of the 1146 responses received, 650 were from pharmacists (56.7%). Among the four methods surveyed, 71.5% of respondents were aware of educational materials, while awareness of the other three methods ranged from 20.7 to 53.9%. Pharmacists had higher awareness of all four methods compared to doctors. Private sector respondents were more aware of DHPCs compared to those from the public sector. The strongest predictors for finding risk communication useful were being a pharmacist [odds ratio (OR) = 18.2; 95% CI: 10.98–30.07; p < 0.001], having ≥30 years’ work experience [OR = 4.9; 95% CI: 1.98–12.08; p < 0.001], and working in the pharmaceutical industry [OR = 4.6; 95% CI: 1.08–19.72; p = 0.039]. Both doctors and pharmacists preferred risk communication in the English-language and electronic format. However, other preferences differed between the professions and sectors. Analysis of free-text comments revealed five core themes to guide risk communication enhancement strategies. CONCLUSIONS: Risk communication awareness differed between public and private sector doctors and pharmacists depending on communication source. Integrating our findings with the theory of effective communication, we provide suggestions for developing strategic plans on enhancing risk communication. Public-private sector collaboration is key in ensuring risk communication effectiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13703-x. |
format | Online Article Text |
id | pubmed-9253255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92532552022-07-05 Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia Panickar, Rema Aziz, Zoriah Kamarulzaman, Adeeba BMC Public Health Research BACKGROUND: Medication risk communication is essential to ensure the safe use of medicines. However, very few nations worldwide have established effective risk communication systems. To date, the effectiveness of risk communication among healthcare professionals in Malaysia has never been evaluated. Our study aimed to (i) evaluate doctors’ and pharmacists’ awareness of regulatory risk communication methods; (ii) identify factors predicting the usefulness of these methods; and (iii) compare respondents’ preferences for risk communication to outline suggestions for enhancement. METHODS: We conducted a nationwide cross-sectional survey covering four commonly used risk communications, namely a national drug bulletin, safety alerts, Direct Healthcare Professional Communication letters (DHPCs), and educational materials. Multiple logistic regression analysis was used to determine the association between independent variables and the usefulness of risk communication. We performed qualitative analysis of free-text responses to gain insights on respondents’ perspectives on risk communication. RESULTS: Of the 1146 responses received, 650 were from pharmacists (56.7%). Among the four methods surveyed, 71.5% of respondents were aware of educational materials, while awareness of the other three methods ranged from 20.7 to 53.9%. Pharmacists had higher awareness of all four methods compared to doctors. Private sector respondents were more aware of DHPCs compared to those from the public sector. The strongest predictors for finding risk communication useful were being a pharmacist [odds ratio (OR) = 18.2; 95% CI: 10.98–30.07; p < 0.001], having ≥30 years’ work experience [OR = 4.9; 95% CI: 1.98–12.08; p < 0.001], and working in the pharmaceutical industry [OR = 4.6; 95% CI: 1.08–19.72; p = 0.039]. Both doctors and pharmacists preferred risk communication in the English-language and electronic format. However, other preferences differed between the professions and sectors. Analysis of free-text comments revealed five core themes to guide risk communication enhancement strategies. CONCLUSIONS: Risk communication awareness differed between public and private sector doctors and pharmacists depending on communication source. Integrating our findings with the theory of effective communication, we provide suggestions for developing strategic plans on enhancing risk communication. Public-private sector collaboration is key in ensuring risk communication effectiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13703-x. BioMed Central 2022-07-05 /pmc/articles/PMC9253255/ /pubmed/35788213 http://dx.doi.org/10.1186/s12889-022-13703-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Panickar, Rema Aziz, Zoriah Kamarulzaman, Adeeba Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia |
title | Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia |
title_full | Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia |
title_fullStr | Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia |
title_full_unstemmed | Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia |
title_short | Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia |
title_sort | enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in malaysia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253255/ https://www.ncbi.nlm.nih.gov/pubmed/35788213 http://dx.doi.org/10.1186/s12889-022-13703-x |
work_keys_str_mv | AT panickarrema enhancingmedicationriskcommunicationindevelopingcountriesacrosssectionalsurveyamongdoctorsandpharmacistsinmalaysia AT azizzoriah enhancingmedicationriskcommunicationindevelopingcountriesacrosssectionalsurveyamongdoctorsandpharmacistsinmalaysia AT kamarulzamanadeeba enhancingmedicationriskcommunicationindevelopingcountriesacrosssectionalsurveyamongdoctorsandpharmacistsinmalaysia |